New York, December 23, 2020 (GLOBE NEWSWIRE) – Reportlinker.com announces the publication of the report “Global market for medical defrost systems by product type, sample type, end use, by region, industrial analysis and forecast, 2020 – 2026” – https://www.reportlinker.com/p05999873/?utm_source=GNW
The biology study is used in drug discovery, biobanking, assisted reproduction, cell therapy, and regenerative drugs. The defrost system is used for transport of biopharmaceutical products and safe storage. There are two significant types of defrost systems, namely. manually and automatically. An automated defrost system has been developed for the rapid defrosting of the living biological substance of a cryogenic bottle of high reproducibility and negligible risk of contamination.
Most defrost systems transfer heat to the surface and then depend on the conductivity to supply that heat to the food center. Some use electromagnetic radiation to produce heat in food. When choosing a defrost system for personal use, the company should strike a balance between defrost time, capital and operating costs of the system, the appearance and microbiological condition of the product, and processing problems such as wastewater disposal. Of these elements, the main criterion is the defrost time that governs the choice of system. Appearance, microbiological status, and weight loss are vital if the material is to be maintained in a thawed state, but are of little importance if the food is used for further processing.
According to the type of product
Based on the type of product, the market is segmented into manual and automated. In 2019, the market was dominated by a manual defrost system with the main market system. The share in the segment is mainly due to the accessibility of a wide range of items and high utilization due to economical prices. The automated defrost system is expected to grow at the fastest rate due to its characteristics such as high adoption rate, ease of use and portability.
According to the type of sample
Based on the type of sample, the market is segmented into blood, egg, semen, embryo and others. The embryo segment is expected to observe profitable development opportunities during the projected period. The high development rate of this segment is mainly due to the growth of the live birth rate due to embryo donation and pregnancy rate. Furthermore, the increasing adoption of in vitro fertilization (IVF) techniques for infertility is driving the demand for advanced thawing systems.
End use
Based on end use, the market is segmented into blood banks and transfusion centers, hospitals, tissue banks, biotechnology and pharmacy, and other end uses. The tissue banking segment is expected to grow at a high rate over the forecast period. Tissue banks are considered institutions that recover and preserve human corpses for medical studies and education. The most commonly stored tissues that are stored and harvested include cartilage, skin, tendons, bone joints, cornea, and dura mater.
By regions
Based on regions, the market is segmented into North America, Europe, the Asia-Pacific region and Latin America, the Middle East and Africa. The Asia-Pacific region will record the highest growth rate over the projected years. The region consists of growing economies, especially China, India and Japan. These states consist of a huge number of patients with a high rate of chronic diseases. An increase in the number of chronic diseases that result in organ failure is expected to boost the demand for thawed blood.
The market research report covers the analysis of key market stakeholders. Key companies presented in the report include General Electric (GE) Co. (GE Healthcare), Thermo Fisher Scientific, Inc., Cardinal Health, Inc., Helmer Scientific, Inc., Sarstedt AG & Company, Boekel Scientific, Inc., Barkey GmbH & Co. KG, BioCision LLC, Sartorius AG and CytoTherm LP.
Strategies applied in the market of medical defrost systems
September 2020: Boekel Scientific announces the FS100, a new floor-standing incubator and high-capacity platelet mixer for platelet storage in hospitals and blood centers. This device can store up to 100 platelet units and uses advanced thermoelectric heating and cooling to maintain platelets at the ideal storage temperature.
June 2020: GE Healthcare acquires Asymptote, a specialist in cryochain technology for sensitive cell therapies. This acquisition has bridged a critical gap in GE Healthcare’s end-to-end ecosystem of cell therapy products and services and is an important part of the portfolio that enables the industrialization of these rescue therapies.
June 2019: Barkey has signed a reseller distribution agreement with FreMon Scientific, a supplier of biomedical devices. Together, the companies aimed to save lives with precision, controlled, reliable technology and protocols for heating and thawing.
Jan-2019: Helmer Scientific unveiled GX Solutions, professional medical refrigerators with OptiCool cooling systems. These refrigerators are designed to store samples of drugs, vaccines, blood and patients. Professional medical refrigerators provide optimized control in three important areas: temperature management, noise management and energy management.
September 2017: GE Healthcare launched the first in its VIA Thaw series, the VIA Thaw CB1000 for defrosting large amounts of cell therapies cryopreserved in cryobags. This range of innovative automated dry thawing units gives users control over the thawing of sensitive therapies and addresses the challenges faced by cell therapy companies.
Scope of the study
Market segments covered by the report:
According to the type of product
• Manual
• Automated
According to the type of sample
• Blood
• Ovum
• Seed
• Embryo
• Other
End use
• Blood bank and transfusion centers
• Hospitals
• Tissue banks
• Biotechnology and pharmacy
• Other end uses
By Geography
• North America
about the USA
o Canada
about Mexico
o The rest of North America
• Europe
o Germany
about the UK
o France
o Russia
o Spain
o Italy
o The rest of Europe
• Asia-Pacific region
about China
about Japan
o India
o South Korea
of Singapore
o Malaysia
o The rest of Asia and the Pacific
• LAMEA
o Brazil
o Argentina
about the UAE
o Saudi Arabia
o South Africa
o Nigeria
o the rest of the LAMEE
Profiling companies
• General Electric (GE) Co. (GE Healthcare)
• Thermo Fisher Scientific, Inc.
• Cardinal Health, Inc.
• Helmer Scientific, Inc.
• Sarstedt AG and company
• Boekel Scientific, Inc.
• Barkey GmbH & Co. KG
• BioCision LLC
• Sartorius AG
• CytoTherm LP
Unique offers
• Exhaustive coverage
• Largest number of market tables and figures
• Subscription-based model available
• Best price guaranteed
• Provided after-sales research support with 10% free customization
Read the full report: https://www.reportlinker.com/p05999873/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – right now, in one place.
__________________________
Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001